“…In effect, by localizing the delivery of TNF to solid tumors, Lienard and Lejuene harnessed the biology of TNF to induce at least one of the possible mechanisms by which the cytokine induces an anti-tumor response. For example, TNF has been shown to cause apoptosis directly in various tumor cell types Helson et al, 1975], to activate and drive immune-based anti-tumor responses [Asami et al, 1989], and to induce vascular leak in tumor blood vessels [Nawroth and Stern, 1986;Brett et al, 1989], leading to a destruction of the interstitial fluid pressure (IFP) gradient in solid tumors [Kristensen et al, 1996;Nedrebo et al, 1999]. Thus, the rational design of nanotherapeutics that simulate this surgical procedure may prove to be an effective strategy to developing new tumor-targeted therapies.…”